Gordius (Gabapentin)

Gordius (gabapentin) is prescribed for several neurologic and pain‑related conditions that involve abnormal neuronal excitability.

• Adjunct therapy for partial seizures in adults.
• Management of postherpetic neuralgia.
• Treatment of neuropathic pain associated with diabetic peripheral neuropathy.
• Relief of symptoms in restless legs syndrome.
• Off‑label use for certain anxiety disorders as determined by a physician.

Side effects reported with gabapentin vary in frequency and severity.

Common

• Dizziness.
• Somnolence.
• Peripheral edema.
• Visual disturbances.
• Weight gain.

Serious

• Severe allergic reactions such as Stevens‑Johnson syndrome.
• Suicidal thoughts or behavior.
• Acute respiratory depression, especially when combined with other central nervous system depressants.

Before initiating Gordius, clinicians should evaluate several safety considerations to minimize risk.

• Assess renal function; dose adjustment may be required in impairment.
• Review pregnancy and breastfeeding status; category B but benefits vs risks must be weighed.
• Monitor for mood changes, including depression or suicidal ideation.
• Caution in patients with a history of hypersensitivity to gabapentin or related compounds.
• Avoid abrupt discontinuation to reduce withdrawal symptoms.
• Consider potential for misuse in individuals with substance‑use disorders.

Gabapentin can interact with other medicines, affecting its effectiveness or safety.

Avoid

• Concurrent use with antacids containing aluminum or magnesium may reduce absorption.
• Co‑administration with CNS depressants (e.g., opioids, benzodiazepines) may increase sedation.

Use with caution

• Combination with other anticonvulsants may require dose adjustments.
• Use with alcohol may enhance central nervous system effects.
• Interaction with renal‑clearing drugs (e.g., NSAIDs) may affect gabapentin levels.